A Video Intervention to Decrease Patient Fear of Colonoscopy After a Positive Fecal Immunochemical Test
NCT ID: NCT05458986
Last Updated: 2024-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2023-05-15
2024-05-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NCT05612347
Assessing the Effect of a Blood-based Colorectal Cancer Screening Test on Screening Adherence and Colonoscopy Completion
NCT03598166
FIT Mailing Protocol-For Cancer Screening Navigation
NCT02934958
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
NCT06568016
Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT
NCT06173375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ARM 1: Patients watch an educational video about the importance of abnormal FIT results, the implications if follow-up colonoscopy is not completed, and demonstrate the steps to complete a colonoscopy.
ARM 2: Patients receive usual care and do not watch the educational video.
After completion of study, patients are followed for 12 months after their abnormal FIT result.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1 (educational video)
Patients watch an educational video about the importance of abnormal FIT results, the implications if follow-up colonoscopy is not completed, and demonstrate the steps to complete a colonoscopy.
Media Intervention
Watch an educational video
Questionnaire Administration
Ancillary studies
Arm 2 (usual care)
Patients receive usual care and do not watch the educational video.
Best Practice
Receive usual care
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Media Intervention
Watch an educational video
Best Practice
Receive usual care
Questionnaire Administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have an assigned primary care provider in our partnering safety-net health system
* Have a billable primary care encounter between 2019-2022
* Have an abnormal FIT result for colorectal cancer (CRC) screening without a colonoscopy within 1 year
* Ability to communicate in English due to initial videos being available in English
Exclusion Criteria
* Patients who receive care at other University of Washington (UW) medicine sites (non-safety-net patients)
* Individuals without a primary care encounter between 2019-2022
* Individuals whose primary language is not English
45 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American College of Gastroenterology
OTHER
Fred Hutchinson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rachel Issaka, MD, MAS
Role: PRINCIPAL_INVESTIGATOR
Fred Hutch/University of Washington Cancer Consortium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2022-05223
Identifier Type: REGISTRY
Identifier Source: secondary_id
10950
Identifier Type: OTHER
Identifier Source: secondary_id
RG1122309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.